Jaguar Animal Health (NASDAQ:JAGX) Posts Quarterly Earnings Results, Misses Estimates By $1.20 EPS

Jaguar Animal Health (NASDAQ:JAGX) posted its quarterly earnings data on Friday. The biotechnology company reported ($6.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($5.08) by ($1.20), FiscalAI reports. Jaguar Animal Health had a negative return on equity of 660.18% and a negative net margin of 344.16%.The business had revenue of $3.08 million during the quarter, compared to analysts’ expectations of $3.73 million.

Jaguar Animal Health Price Performance

Shares of Jaguar Animal Health stock traded up $0.08 during trading on Friday, reaching $1.78. 55,507 shares of the stock traded hands, compared to its average volume of 75,054. The company has a debt-to-equity ratio of 2.44, a current ratio of 0.95 and a quick ratio of 0.59. The company has a market capitalization of $3.86 million, a price-to-earnings ratio of -0.03 and a beta of 0.50. Jaguar Animal Health has a 52-week low of $1.57 and a 52-week high of $33.25. The business has a fifty day simple moving average of $2.00 and a two-hundred day simple moving average of $3.17.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Jaguar Animal Health in a research note on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $60.00.

Jaguar Animal Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.